Disgruntled Nobel loser sues; brain trauma researchers search for biomarker of a chronic condition; receptor for novel coronavirus found; the rise of transcriptomics; and ethical oversight of participant-led research
The Scientist
Most Recent
Researchers identify the target protein of a recently discovered human coronavirus, shedding light on infection and possible interspecies spread.
Tailoring ethical oversight to participant-led research
The method to the dengue virus's maddening infectiousness.
Although fully organized patient-run trials are still few and far between, patients are taking a more active role in clinical research.
The global spread of dengue virus has immunologists and public-health experts debating the best way to curb infection.
Patients are sidestepping clinical research and using themselves as guinea pigs to test new treatments for fatal diseases. Will they hurt themselves, or science?
March 2013 Scientist to Watch Emily Scott explains her work on a lung enzyme that interacts with nicotine and may serve as a drug target.
The first human trial of a treatment using induced pluripotent stem cells has received conditional approval from an institutional review board in Japan.
A study suggests that some mouse models do not accurately mimic human molecular mechanisms of inflammatory response, but other mouse strains may fare better.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
